Skip to main content

Table 2 Effects of rosiglitozane on MDA content and SOD activity (n = 5)

From: PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status

Group SOD MDA
  (ng/ml) (ng/ml)
sham control 71.58 ± 6.23 1.74 ± 0.14
IR 37.24 ± 5.16** 2.33 ± 0.19**
0.8 mg/kg Ros 40.37 ± 4.32** 2.14 ± 0.15**
2.4 mg/kg Ros 49.37 ± 7.25**## 1.97 ± 0.17*##
7.2 mg/kg Ros 55.47 ± 9.31## 1.89 ± 0.21##
7.2 mg/kg Ros plus GW9662 35.31 ± 6.11** 2.44 ± 0.17**
GW9662 in sham control 69.43 ± 4.57 1.83 ± 0.24
  1. Datas are expressed as mean ± SD (n = 5). * and **:P < 0.05 and 0.01, vs. sham control; # and ##:P < 0.05 and 0.01 vs. IR.